These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 6315778)
1. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition. Mann JJ J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778 [No Abstract] [Full Text] [Related]
2. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307 [TBL] [Abstract][Full Text] [Related]
3. Refractory depression treated with high doses of monoamine oxidase inhibitor. Guze BH; Baxter LR; Rego J J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984 [TBL] [Abstract][Full Text] [Related]
4. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nolen WA Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774 [TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase inhibitors revisited: what you should know. Goldberg JF; Thase ME J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352 [No Abstract] [Full Text] [Related]
6. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation. Christmas AJ; Hall DW; Hayward A; Maxwell DR Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104 [No Abstract] [Full Text] [Related]
8. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge]. Volz HP; Gleiter CH; Möller HJ Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342 [TBL] [Abstract][Full Text] [Related]
9. Relationship between tranylcypromine sulfate dose and monoamine oxidase inhibition. Grasso RA; Perry PJ; Sherman AD DICP; 1991 Jan; 25(1):99-100. PubMed ID: 2008794 [No Abstract] [Full Text] [Related]
10. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method. Bartonícek V Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397 [No Abstract] [Full Text] [Related]
11. Do monoamine oxidase inhibitors alter carbamazepine blood levels? Barklage NE; Jefferson JW; Margolis D J Clin Psychiatry; 1992 Jul; 53(7):258. PubMed ID: 1639748 [No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763 [TBL] [Abstract][Full Text] [Related]
20. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression. Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]